Merit Medical Marks Milestone in Breast Cancer Treatment Innovation
Milestone Achievement in Breast Cancer Treatment
Merit Medical Systems, Inc. (NASDAQ: MMSI), renowned for its innovative healthcare technology solutions, has achieved a remarkable milestone: the SCOUT® Radar Localization system has successfully treated 750,000 patients globally. This achievement is especially significant during Breast Cancer Awareness Month, a period dedicated to raising awareness about breast cancer, promoting early detection, and exploring quality treatment options available to individuals.
Understanding the Impact of Breast Cancer
This year, it’s anticipated that more than 300,000 new cases of invasive breast cancer will be diagnosed in women, highlighting the ongoing need for effective solutions. As a leader in wire-free non-radioactive localization technology, Merit Medical is committed to alleviating the difficult burdens that cancer imposes on patients and their families. The SCOUT technology allows healthcare providers to accurately target and remove cancerous tissue, resulting in procedures that are less traumatic for patients.
How SCOUT Works
SCOUT employs an innovative reflector, about the size of a grain of rice, which facilitates surgery with an accuracy of +/- 1 mm. This precision can lead to better surgical outcomes and patient experiences. The system is versatile, supporting various treatment needs, whether for breast tissue or lymph nodes, and is useful both prior to and following neoadjuvant chemotherapy. SCOUT is also effective at the time of biopsy, and its bracketing technique aids in targeting larger or multifocal tumors for breast-conserving therapies.
Expanding the Horizons of Surgical Localization
In its continuous quest to improve surgical localization, Merit Medical introduced SCOUT MD™, a next-generation system that offers four unique reflector shapes equipped with distinct radar signals. This innovation enhances the mapping of tumor margins and allows for the localization of multiple lesions or lymph nodes, further improving the efficacy of treatment.
Recognized for Excellence
The SCOUT technology has gained international recognition, being cited in over 100 clinical publications, which involve nearly 8,500 patients. The system has been adopted across 50 countries, with upwards of 500 procedures performed daily, resulting in an impressive 10,000 cases anticipated each month. Over 1,100 facilities worldwide opt for SCOUT as their preferred wire-free localization method, demonstrating the trust placed in its effectiveness by medical professionals.
Commitment to Patient Care and Community Support
“We are thrilled to witness the positive influence SCOUT has had on countless patients, particularly during Breast Cancer Awareness Month,” expressed Fred Lampropoulos, Chairman and CEO of Merit Medical. “Our support for individuals living with breast cancer goes beyond this month; through innovations like SCOUT, we strive to aid more patients in their journey to becoming cancer-free.”
About Merit Medical
Founded in 1987, Merit Medical Systems, Inc. focuses on developing, manufacturing, and distributing proprietary medical devices intended for interventional and diagnostic procedures in various specialties, including cardiology, radiology, oncology, and endoscopy. With a robust clinical support team and sales force comprising over 800 professionals, Merit serves healthcare providers worldwide. The company is proud to employ approximately 7,300 individuals across the globe, dedicated to advancing healthcare solutions.
Frequently Asked Questions
What is the SCOUT Radar Localization technology?
The SCOUT technology is a wire-free, non-radioactive localization system designed to assist surgeons in accurately targeting and removing breast cancer tissue.
How many patients have been treated with SCOUT?
SCOUT has treated over 750,000 patients around the world, marking a significant milestone in its usage.
Where has SCOUT technology been adopted?
SCOUT technology has been utilized in more than 50 countries and is the preferred choice for over 1,100 medical facilities globally.
What is the next-generation SCOUT MD™ system?
SCOUT MD™ is an advanced version of the original SCOUT system, providing enhanced tumor margin mapping with its specialized reflector shapes and radar signals.
How does Merit Medical support breast cancer patients?
Merit Medical is committed to supporting breast cancer patients through innovative products like SCOUT, continual education, and advocacy during Breast Cancer Awareness Month and beyond.
About The Author
Contact Dominic Sanders privately here. Or send an email with ATTN: Dominic Sanders as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.